New hope for advanced cancers: experimental drug EIK1005 enters human trials

NCT ID NCT07262619

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called EIK1005, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug shrinks tumors. About 160 adults with certain cancer types (including MSI-H or dMMR tumors) will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Calvary Mater Newcastle Hospital

    RECRUITING

    Waratah, New South Wales, Australia

  • Chris O'Brien Lifehouse (Sydney Cancer Centre)

    RECRUITING

    Camperdown, Victoria, Australia

  • GenesisCare North Shore (Oncology)

    NOT_YET_RECRUITING

    Saint Leonards, New South Wales, Australia

  • Grampians Health

    RECRUITING

    Ballarat, Victoria, Australia

  • Health New Zealand

    RECRUITING

    Wellington, New Zealand

  • Memorial Sloan Kettering Cancer Center (MSKCC)

    NOT_YET_RECRUITING

    New York, New York, 10022, United States

  • Morristown Medical Center

    NOT_YET_RECRUITING

    Morristown, New Jersey, 07960, United States

  • Oncology Clinics Victoria (OCV) - Cabrini Brighton Hospital

    NOT_YET_RECRUITING

    Frankston, Victoria, 3199, Australia

  • Peninsula and Southeast Oncology (PASO) Medical

    RECRUITING

    Frankston, Victoria, Australia

  • University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.